|Jody Cain||Investor Relations|
|Jerry Jabbour||Chief Executive Officer|
|Keith Kucinski||Chief Financial Officer|
|Terry Matkovits||Chief Development Officer|
|Greg Fraser||Truist Securities|
Greetings and welcome to the Matinas BioPharma 2022 Fourth Quarter and Full Year Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jody Cain. Thank you, Jody.
You may begin.